Search results for "Confidence Intervals"

showing 10 items of 111 documents

Objective Bayesian point and region estimation in location-scale models.

2007

Point and region estimation may both be described as specific decision problems. In point estimation, the action space is the set of possible values of the quantity on interest; in region estimation, the action space is the set of its possible credible regions. Foundations dictate that the solution to these decision problems must depend on both the utility function and the prior distribution. Estimators intended for general use should surely be invariant under one-to-one transformations, and this requires the use of an invariant loss function; moreover, an objective solution requires the use of a prior which does not introduce subjective elements. The combined use of an invariant informatio…

Intrinsic LossTeoria de la decisióRegion Estimation:62 Statistics::62B Sufficiency and information [Classificació AMS]Intrinsic DiscrepancyStatisticsEstadísticaReference Analysis:MATEMÁTICAS::Estadística [UNESCO]UNESCO::MATEMÁTICAS::EstadísticaCredible RegionsConfidence Intervals ; Credible Regions ; Decision Theory ; Intrinsic Discrepancy ; Intrinsic Loss ; Location-Scale Models ; Noninformative Prior ; Reference Analysis ; Region Estimation ; Point EstimationPoint EstimationDecision TheoryInferenceInferència:62 Statistics::62F Parametric inference [Classificació AMS]Confidence IntervalsLocation-Scale ModelsNoninformative Prior:62 Statistics::62C Decision theory [Classificació AMS]
researchProduct

Body weight dissatisfaction and communication with parents among adolescents in 24 countries: international cross-sectional survey

2009

Abstract Background Parents have significant influence on behaviors and perceptions surrounding eating, body image and weight in adolescents. The aim of this study was to examine the prevalence of body weight dissatisfaction, difficulty in communication with the parents and the relationship between communication with parents and adolescents' dissatisfaction with their body weight (dieting or perceived need to diet). Methods Survey data were collected from adolescents in 24 countries and regions in Europe, Canada, and the USA who participated in the cross-sectional 2001/2002 Health Behaviour of School-Aged Children (HBSC) study. The association between communication with parents and body wei…

MaleADULT ATTACHMENTBOYSInternationalityIMAGECross-sectional studyHealth BehaviorNON-OVERWEIGHT ADOLESCENTSOverweightBody Mass IndexDevelopmental psychologyFAMILY MEALSMedicine and Health SciencesParent-Child RelationsChildRISKCommunicationlcsh:Public aspects of medicineAge FactorsLOSE WEIGHTFamily lifeEuropeGIRLSFemalemedicine.symptomMENTAL-HEALTHResearch ArticleDietingCanadamedicine.medical_specialtyAdolescentBEHAVIORSRisk AssessmentSex FactorsBody ImageConfidence IntervalsmedicineHumansObesityPsychiatryProbabilitybusiness.industryPublic healthBody WeightPublic Health Environmental and Occupational Healthlcsh:RA1-1270Overweightmedicine.diseaseObesityMental healthSelf ConceptUnited StatesCross-Sectional StudiesLogistic ModelsAdolescent BehaviorbusinessBody mass indexBMC Public Health
researchProduct

Independent and Combined Association of Physical Activity and Cardiac Disease on Mortality Risk in the Very Old

2010

Objectives: This study investigated physical activity as a predictor of all-cause mortality among 75- and 80-year-old people with and without chronic cardiac disease over a 10-year follow-up period. Method: Using the Evergreen Project data, four study groups were formed according to the respondent’s self-reported level of physical activity as well as chronic cardiac diseases: active without cardiac disease (control group = ANCD), active with cardiac disease (ACD), sedentary without cardiac disease (SNCD), and sedentary with cardiac disease (SCD). Results: In the analyses, the ACD (HR 1.69, 95% CI 1.02-2.81) and the SNCD (1.76, 1.14-2.73) groups had almost one and a half times greater risk …

MaleAgingStudy groupsmedicine.medical_specialtyPhysical activityDiseaseMotor ActivityRisk FactorsInternal medicineConfidence IntervalsHumansMedicineMortalityFinlandAgedAged 80 and overCommunity and Home CareChi-Square Distributionbusiness.industryCardiovascular DiseasesChronic DiseaseMultivariate AnalysisPhysical therapyFemaleSelf ReportSedentary BehaviorGeriatrics and GerontologybusinessOlder peopleGerontologyLower mortalityAll cause mortalityJournal of Aging and Health
researchProduct

Childhood acute lymphoblastic leukaemia and birthweight: Insights from a pooled analysis of case–control data from Germany, the United Kingdom and th…

2012

Abstract Background Heavy birthweight is one of the few established risk factors for childhood acute lymphoblastic leukaemia (ALL). To provide new insight into this relationship, particularly at the extremes ( 4500 g), we pooled data from three of the largest childhood cancer case–control studies ever conducted. Methods Birthweight and gestational age on 4075 children with ALL and 12,065 controls were collected during the course of three studies conducted in the USA, the UK and Germany in the 1990s. Information was obtained from mothers at interview, and the impact of bias was evaluated using the UK study which accessed birth registrations of participants and non-participants. Odds ratios (…

MaleCancer ResearchPediatricsmedicine.medical_specialtyAdolescentGestational AgeLogistic regressionRisk FactorsGermanyEpidemiologyConfidence IntervalsOdds RatioBirth WeightHumansMedicineRegistriesChildbusiness.industryInfant NewbornInfantGestational ageOdds ratioPrecursor Cell Lymphoblastic Leukemia-LymphomaUnited KingdomUnited StatesConfidence intervalLow birth weightLogistic ModelsOncologyCase-Control StudiesChild PreschoolEtiologyGestationFemalemedicine.symptombusinessDemographyEuropean Journal of Cancer
researchProduct

Effect of self-regulatory behaviour change techniques and predictors of physical activity maintenance in cancer survivors: a 12-month follow-up of th…

2021

Abstract Background Current knowledge about the promotion of long-term physical activity (PA) maintenance in cancer survivors is limited. The aims of this study were to 1) determine the effect of self-regulatory BCTs on long-term PA maintenance, and 2) identify predictors of long-term PA maintenance in cancer survivors 12 months after participating in a six-month exercise intervention during cancer treatment. Methods In a multicentre study with a 2 × 2 factorial design, the Phys-Can RCT, 577 participants with curable breast, colorectal or prostate cancer and starting their cancer treatment, were randomized to high intensity exercise with or without self-regulatory behaviour change technique…

MaleCancer ResearchTime FactorsCancer survivorsLogistic regressionBody Mass Indexlaw.inventionTobacco UseProstate cancerRandomized controlled trialBehavior TherapylawOdds RatioMedicineRC254-282DeterminantsHigh intensityNeoplasms. Tumors. Oncology. Including cancer and carcinogensBehaviour changeMiddle AgedBehavioural supportEndurance TrainingVDP::Medisinske Fag: 700::Helsefag: 800OncologySelf-regulationRegression AnalysisFemaleColorectal NeoplasmsMonth follow upmedicine.medical_specialtyBehaviour changeMaintenancePhysical activityBreast NeoplasmsSelf-ControlConfidence IntervalsGeneticsHumansExerciseSwedenMotivationCancer och onkologibusiness.industryResearchProstatic NeoplasmsCancerResistance Trainingmedicine.diseaseActigraphyCancer and OncologyQuality of LifePhysical therapybusinessFollow-Up StudiesBMC Cancer
researchProduct

Malignant germ cell tumors in childhood: results of the first Italian cooperative study "TCG 91".

2003

Background and Aims About 20% of patients with germ cell tumor (GCT) are still resistant to therapy. To investigate which features are present in resistant patients, a multicenter study on GCT in children was undertaken to correlate clinical and laboratory parameters with the outcome. Methods Patients aged less than 16 years, with histologically proven extracranial GCT were included. Results Ninety-five patients (median age 33 months, 45 males) were eligible. The site of the primary tumor was gonadal in 59, extragonadal in 36. The stage was I in 39; II in 5; IIIa (microscopic residue) in 7; IIIb (macroscopic residue) in 16; IIIc (unresectable) in 13; IV in 15. The treatment was surgery alon…

MaleCancer Researchmedicine.medical_treatmentGastroenterologyCohort Studieschemistry.chemical_compoundChildmalignant germ cell tumorsEtoposideOvarian NeoplasmsIfosfamideIncidenceseminomaPrognosisCombined Modality TherapyPrimary tumorChemotherapy regimenTreatment OutcomeItalyOncologyChild PreschoolcarboplatinFemaleGerminomamedicine.drugmedicine.medical_specialtyAdolescentRisk Assessmentrisk factors in malignant germ cellAge Distributioncarboplatin; malignant germ cell tumors; risk factors in malignant germ cell; seminomaTesticular NeoplasmsInternal medicineConfidence IntervalsmedicineHumansSex DistributionSurvival analysisNeoplasm StagingProbabilityRetrospective StudiesChemotherapybusiness.industrySeminomamedicine.diseaseSurvival AnalysisCarboplatinSurgerychemistryMultivariate AnalysisPediatrics Perinatology and Child Healthbusiness
researchProduct

Test-retest reliability of selected items of Health Behaviour in School-aged Children (HBSC) survey questionnaire in Beijing, China

2010

Abstract Background Children's health and health behaviour are essential for their development and it is important to obtain abundant and accurate information to understand young people's health and health behaviour. The Health Behaviour in School-aged Children (HBSC) study is among the first large-scale international surveys on adolescent health through self-report questionnaires. So far, more than 40 countries in Europe and North America have been involved in the HBSC study. The purpose of this study is to assess the test-retest reliability of selected items in the Chinese version of the HBSC survey questionnaire in a sample of adolescents in Beijing, China. Methods A sample of 95 male an…

MaleChinalcsh:R5-920AdolescentEpidemiologySubstance-Related DisordersHealth BehaviorChild BehaviorReproducibility of Resultsbehavioral disciplines and activitiesLeisure ActivitiesAdolescent BehaviorSurveys and QuestionnairesConfidence IntervalsHumansFemaleChildSleepStudentslcsh:Medicine (General)ExerciseQualitative ResearchResearch ArticleBMC Medical Research Methodology
researchProduct

A Pooled Analysis of Reproductive Factors, Exogenous Hormone Use, and Risk of Multiple Myeloma among Women in the International Multiple Myeloma Cons…

2015

Abstract Background: Female sex hormones are known to have immunomodulatory effects. Therefore, reproductive factors and exogenous hormone use could influence the risk of multiple myeloma in women. However, the role of hormonal factors in multiple myeloma etiology remains unclear because previous investigations were underpowered to detect modest associations. Methods: We conducted a pooled analysis of seven case–control studies included in the International Multiple Myeloma Consortium, with individual data on reproductive factors and exogenous hormone use from 1,072 female cases and 3,541 female controls. Study-specific odds ratios and corresponding 95% confidence intervals (CI) were estima…

MaleEpidemiologymedicine.medical_treatmentPhysiology[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineRisk FactorsOdds RatioGonadal030212 general & internal medicineReproductive HistoryMultiple myelomaIncidenceMiddle AgedStatisticalPrognosis3. Good healthPostmenopauseContraceptionOncologyTransgender hormone therapy030220 oncology & carcinogenesisMeta-analysisRegression AnalysisFemaleMultiple MyelomaFactor AnalysisAdultHormone Replacement Therapy[SDV.CAN]Life Sciences [q-bio]/CancerArticle03 medical and health sciencesYoung AdultMeta-Analysis as TopicReproductive factors exogenous hormone use and risk of multiple myelomamedicineConfidence IntervalsHumansNeoplasm StagingSteroid Hormonesbusiness.industryCase-control studyOdds ratiomedicine.diseaseHormonesLogistic ModelsHormonal contraceptionCase-Control StudiesSample SizeImmunologyHormone therapybusinessHormoneFollow-Up StudiesMeta-Analysis
researchProduct

Midlife muscle strength and human longevity up to age 100 years: a 44-year prospective study among a decedent cohort

2011

We studied prospectively the midlife handgrip strength, living habits, and parents’ longevity as predictors of length of life up to becoming a centenarian. The participants were 2,239 men from the Honolulu Heart Program/Honolulu–Asia Aging Study who were born before the end of June 1909 and who took part in baseline physical assessment in 1965–1968, when they were 56–68 years old. Deaths were followed until the end of June 2009 for 44 years with complete ascertainment. Longevity was categorized as centenarian (≥100 years, n = 47), nonagenarian (90–99 years, n = 545), octogenarian (80–89 years, n = 847), and ≤79 years (n = 801, reference). The average survival after baseline was 20.8 years (…

MaleGerontologyAgingTime FactorsInter-generationalmedia_common.quotation_subjectLongevityMuscle Strength DynamometerMotor ActivityHawaiiArticle03 medical and health sciencesGrip strength0302 clinical medicinePredictive Value of TestsHand strengthConfidence IntervalsOdds RatioGeriatrics/GerontologyHumansProspective Studies030212 general & internal medicineMortalityProspective cohort studyAgedmedia_commonAged 80 and overHand StrengthLongevityLife SciencesCell BiologyGeneral MedicineOdds ratioMiddle AgedPrognosisConfidence intervalSurvival RateAgeingGrip strengthCohortMolecular MedicineFemaleCentenarianGeriatrics and GerontologyPsychology030217 neurology & neurosurgeryFollow-Up StudiesHumanAGE
researchProduct

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

2016

Transmitted human immunodeficiency virus drug resistance in Europe is stable at around 8%. The impact of baseline mutation patterns on susceptibility to antiretroviral drugs should be addressed using clinical guidelines. The impact on baseline susceptibility is largest for nonnucleoside reverse transcriptase inhibitors.

MaleHuman immunodeficiency virus 1EtravirineRNA directed DNA polymerase inhibitordarunavirHIV InfectionsSettore MED/42 - Igiene Generale E Applicata:Disciplines and Occupations::Health Occupations::Medicine::Public Health [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Salud públicageneticsInhibidores de proteasas:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence [Medical Subject Headings]atazanavirmedia_commontransmission:Geographicals::Geographic Locations::Europe [Medical Subject Headings]3. Good healthmicrobial sensitivity testpriority journalEurope ; HIV-1 ; antiretroviral therapy ; drug resistance ; transmissionHIV/AIDSlamivudineReverse Transcriptase Inhibitors/pharmacologyanti human immunodeficiency virus agentDrugMicrobiology (medical)medicine.medical_specialtyantiviral susceptibility:Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation [Medical Subject Headings]media_common.quotation_subjectantiretroviral therapy030106 microbiologyHIV Infections/drug therapy:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Reverse Transcriptase Inhibitors [Medical Subject Headings]Microbial Sensitivity TestsRILPIVIRINEArticleEFAVIRENZ03 medical and health sciencestransmitted drug resistanceSDG 3 - Good Health and Well-beingHumansTransmissionhuman:Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Drug Resistance [Medical Subject Headings]REVERSE-TRANSCRIPTASE INHIBITORSRilpivirinaINTEGRASEMUTATIONSabacavirmajor clinical studyVirologyInfecciones por VIHRegimenAntiretroviral therapy; Drug resistance; Europe; HIV-1; Transmission; Medicine (all); Microbiology (medical); Infectious DiseaseschemistryDrug resistance:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Oxazines::Benzoxazines [Medical Subject Headings]MutationHIV-10301 basic medicinenevirapineDrug resistanceCommunicable diseases:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Confidence Intervals [Medical Subject Headings]chemistry.chemical_compoundantiviral therapyINFECTIONMedicine and Health SciencesPrevalence:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires [Medical Subject Headings]ViralNon-U.S. Gov'tReverse-transcriptase inhibitorantiretrovirus agentResearch Support Non-U.S. Gov'tMedicine (all)Human immunodeficiency virus infected patientMiddle AgedvirologyPREVALENCEAntiretroviral therapyEncuestas y CuestionariosANTIRETROVIRAL TREATMENTEuropeInfectious DiseasesHIV-1/drug effectsHIV Protease Inhibitors/pharmacologyRilpivirineReverse Transcriptase Inhibitors:Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections [Medical Subject Headings]FemaleHIV drug resistancemedicine.drugAdultHuman immunodeficiency virus proteinase inhibitor:Chemicals and Drugs::Organic Chemicals::Nitriles::Rilpivirine [Medical Subject Headings]EfavirenzAnti-HIV AgentsResearch SupportResistencia a medicamentosSettore MED/17 - MALATTIE INFETTIVEantiviral resistanceInternal medicineAnti-HIV Agents/pharmacologyDrug Resistance ViralJournal Articlemedicine:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors [Medical Subject Headings]abacavir plus lamivudineEuropa (Continente)Antiretroviral therapy; Drug resistance; Europe; HIV-1; Transmission; Adult; Anti-HIV Agents; Drug Resistance Viral; Europe; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Prevalence; Reverse Transcriptase Inhibitors; Microbiology (medical); Infectious DiseasesemtricitabinenonhumanIntervalos de confianzadrug resistanceMutaciónAntiretroviral therapy; Drug resistance; Europe; HIV-1; Transmissionbusiness.industryHIVpredictionInhibidores de la transcriptasa inversaHIV Protease InhibitorsHuman immunodeficiency virus 1 infectiontenofovirINDIVIDUALSDrug Resistance Viral/geneticsBenzoxazinasETRAVIRINEdrug effects3121 General medicine internal medicine and other clinical medicinePrevalenciabusiness
researchProduct